Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.

Polito MG, Sisca L, Caruso D, Cosimati A, Ramirez Reinaga CA, Leka E, Santini D, Spinelli GP

Open source

DOI
10.3389/fonc.2026.1903546
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1903546,
  title = {Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.},
  author = {Polito MG and Sisca L and Caruso D and Cosimati A and Ramirez Reinaga CA and Leka E and Santini D and Spinelli GP},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1903546},
  url = {https://doi.org/10.3389/fonc.2026.1903546}
}

RIS

TY  - JOUR
TI  - Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.
AU  - Polito MG
AU  - Sisca L
AU  - Caruso D
AU  - Cosimati A
AU  - Ramirez Reinaga CA
AU  - Leka E
AU  - Santini D
AU  - Spinelli GP
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1903546
UR  - https://doi.org/10.3389/fonc.2026.1903546
ER  - 

APA

MG, P., L, S., D, C., A, C., CA, R. R., E, L., D, S., & GP, S. (2026). Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1903546

Source records